Latest Shareholder Value News

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

Kogan.com Ltd delivered strong FY25 results with significant customer growth and improved cash flow, while Mighty Ape embarks on a strategic recovery aiming for profitability in FY26.

Revolver Resources has upgraded its Dianne Copper Deposit resource with a 140% increase in Indicated material and a 26% rise in copper grade, setting the stage for a targeted mining restart in 2026.

Oceania Healthcare Limited reported a robust 1HY26 performance, marked by increased sales volumes, improved care profitability, and disciplined capital management. The company’s strategic focus on sales, operational excellence, and debt reduction sets a solid foundation for sustainable growth.

SKS Technologies reported a remarkable doubling of profit in FY25, driven by strong organic growth and a strategic acquisition that positions it for rapid expansion in Australia's largest data centre market.

ReadCloud Limited reported a 5% revenue increase to $12.9 million for FY25, alongside a 109% surge in underlying EBITDA to $0.76 million, narrowing its statutory loss by 59%. Strong growth in its VET-in-Schools segment and domestic eBooks sales underpinned this improved financial performance.

IPH Limited reported solid FY25 profit growth driven by Canadian acquisitions and a promising FY26 start despite challenges in Australia and New Zealand. CEO Andrew Blattman announced his retirement for late 2026, marking a pivotal leadership transition.

Dalrymple Bay Infrastructure Limited has reaffirmed its position as the world’s largest metallurgical coal export facility with full contracted capacity through 2028 and unveiled detailed plans for a significant terminal expansion.

North Stawell Minerals reported a strong turnaround in FY2025 with encouraging gold exploration results at Darlington and a successful $2.4 million capital raise, setting the stage for growth.

DPM Metals has announced a significant discovery of high-grade gold equivalent mineralization nearly 300 metres below the Chelopech mine, revealing promising potential to extend the mine’s life and value. The company plans a substantial drilling campaign to further delineate this new zone.

AustChina Holdings has raised $1.5 million through a private placement with Bluestone Energy, aiming to accelerate acquisitions and exploration across its energy and mineral projects.

Island Pharmaceuticals has engaged a top Washington DC government affairs firm to accelerate its US biodefence strategy, focusing on its antiviral drug Galidesivir amid promising FDA regulatory signals.